A novel foam formulation of ketoconazole
Selected Abstract
A novel foam formulation of ketoconazole 2% for the treatment of seborrheic dermatitis on multiple body regions.(Clinical report)
Abstract Background: A novel topical foam formulation of ketoconazole has been developed for use on the scalp, body, and face. Objective: To evaluate the efficacy and safety of twice-daily treatment with ketoconazole 2% foam for seborrheic dermatitis on the scalp, body, and face. Methods: One ...
October 1, 2007; Journal of Drugs in Dermatology
Read the full article with a free-trial membership at HighBeam Research
Related Articles 1.
A novel foam formulation of ketoconazole 2% for the treatment of seborrheic dermatitis on multiple body regions.(Clinical report)
|